Cardiac cramp, or angina pectoris, is a common heart condition: about 450,000 Dutch people suffer from heart cramps. The condition is a result of one or more coronary artery constrictions, and leads to attacks of oppressive or oppressive chest pain. The pain can cause an oppressive feeling, and sometimes radiates to the arms, neck, jaw, back or stomach area. Even though these patients are well monitored and treated, they are still at risk of more severe heart failure. These symptoms often have a major impact on the patient's daily functioning.
Current treatment of angina pectoris
The treatment of heart cramps currently consists mainly of administering medication. Often these patients are also treated with a doctor's treatment or bypass surgery. However, a large recent study and meta-analysis have not shown any beneficial effects of these costly and invasive procedures.
Is the life-style solution for the treatment of heart cramps?
It is well known that a modified lifestyle can significantly improve the health of these patients. However, there are no studies that compare the effects of lifestyle adjustments and surgery. PRO-FIT research should change this. It examines whether a lifestyle intervention after one year leads to better results than a doctor's treatment or bypass surgery in patients with stable angina pectoris.
The research is a broad collaboration of academic hospitals Radboudumc, AMC and MUMC+, Máxima MC and Catharina Ziekenhuis, Wageningen University, Leiden University and TU/e, patient association Harteraad, Chronisch Zorgnet (national network of specialized care providers in movement and lifestyle), MiBida (provider of safe care communication) and Cardiovitaal cardiac rehabilitation center.
Structure of the research into lifestyle and heart spasms
Approximately 200 patients from five hospitals are randomly divided into two groups: one group receives the usual treatment. The other group receives a lifestyle intervention. This consists of nutritional coaching and an intensive training program at the physiotherapist, followed by remote guidance using an app and an activity tracker.
Hareld Kemps, main applicant for the grant and cardiologist in Máxima MC: "This is the first study to investigate lifestyle interventions for these patients. If the results are positive, it will have a major impact on the daily care of these patients. Then we can largely replace that care with a less invasive, cheaper and more sustainable treatment".
How do we tackle a lifestyle change?
The research must also answer the question of how such lifestyle treatment can be used in healthcare practice. Dick Thijssen, research project leader and cardiovascular physiologist at Radboudumc: "It is a challenge to implement lifestyle interventions nationwide. This requires a change in both patients and cardiologists. Both groups have to get used to the idea that changing your lifestyle under the guidance of health care providers is a good or even better treatment. In order to maximize the chances of success, we are therefore working with a nationwide network of physiotherapists, Harteraad and the Dutch Society for Cardiology.
Related news items
Rob Aarnoutse is appointed as professor in Translation pharmacology of antimicrobial agents in particular drugs for tuberculosis25 January 2021
Hospital pharmacist and clinical pharmacologist Rob Aarnoutse is appointed as professor in ‘Translation pharmacology of antimicrobial agents, in particular drugs for tuberculosis’ at Radboud University / Radboudumc, starting 16 November 2020.read more
Oral health research makes significant impact at the 148th WHO Executive Board meeting25 January 2021
During the 148th session of the World Health Organization (WHO) Executive Board meeting, Member States passed a game-changing resolution on oral health. WHO Director General Dr Tedros Adhanom Ghebreyesus called it a “landmark resolution”.read more
Radiation boost lowers risk of prostate cancer recurrence21 January 2021
An additional external-beam radiation dose delivered directly to the tumor can benefit the prospects of men with non-metastatic prostate cancer, without causing additional side effects. The risk of relapse within five years for these men is smaller than for men who did not receive this boost.read more
New research through grants for Radboudumc researchers14 January 2021
Several researchers at the Radboudumc have received grants to start new studies, including on rare diseases, liver disease and cancer metastases. These are grants from the Dutch Research Council, European Joint Programme on Rare Diseases and the Gastric Liver Disease Foundation.read more
RIMLS online award ceremony proudly presenting the winners13 January 2021
In this special webinar of the RIMLS New Year Celebration, scientific director René Bindels reviewed 2020 and looked forward to 2021. But more importantly a number of researchers received prizes in the traditional RIMLS awards ceremony.read more
Cooling vests alleviate perceptual heat strain perceived by COVID-19 nurses11 January 2021
Wearing cooling vests during a COVID-19 shift ensures that nurses experience less heat during their work. The cooling vests offer such effective cooling that they are now part of the standard work clothing for nurses in the COVID nursing departments at Radboudumc.read more